Pharmabiz
 

Cosmo Bio to assume leadership position to promote Enzo Life Sciences' products in Japan

New YorkWednesday, March 21, 2012, 15:00 Hrs  [IST]

Enzo Biochem Inc. has signed expanded distribution agreement between its wholly owned subsidiary, Enzo Life Sciences, and Tokyo-based Cosmo Bio Co., Ltd.

Under the terms of the arrangement, Cosmo Bio, a distributor of Enzo Life Sciences products in Japan for over 20 years—will assume a leadership position in Japan in the promotion, sales, and high level technical and customer support for Enzo Life Sciences products. In addition, Enzo will make Cosmo Bio’s extensive catalog of Japanese manufactured research biotools, for which it is a leading distributor, available to researchers around the world through Enzo’s extensive global distribution network. This arrangement materially widens the span of biosciences products offered by both companies and increases the accessibility of the collective portfolio to customers worldwide.

“Cosmo Bio is a leading distributor of research products and custom services to Japan’s academic, pharmaceutical and biotech communities, and expansion of our relationship with Cosmo Bio will provide Japan’s researchers with improved access to a broader range of Enzo products backed by extensive and efficient technical and sales support,” said Barry Weiner, president of Enzo Biochem.

Dr Haruhisa Sakurai, a company director at Cosmo Bio Co., Ltd. commented that we are proud to strengthen our relationship with Enzo Life Sciences. Cosmo Bio and Enzo share similar company core values in their dedication to supplying quality products and delivering outstanding customer service to the world marketplace. Our expanded alliance with Enzo and the introduction of thousands of Japanese manufactured biotools to be offered by Cosmo Bio’s export division through Enzo Life Sciences’s worldwide distribution system further expands the choices and opportunities available to our customers worldwide.

Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and therapeutics through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards.

Cosmo Bio Co., Ltd. is one of Japan’s largest direct importers of reagent-based products and small instruments for life science research.

 
[Close]